Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

Programmed Death Ligand 1 (PD-L1) positivity rates differ between different metastatic sites and the primary tumor. Understanding PD-L1 expression characteristics could guide biopsy procedures and motivate research to better understand site-specific differences in the tumor microenvironment. The pur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Rozenblit, Mariya, Huang, Richard, Danziger, Natalie, Hegde, Priti, Alexander, Brian, Ramkissoon, Shakti, Blenman, Kim, Ross, Jeffrey S, Rimm, David L, Pusztai, Lajos
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Immunotherapy Biomarkers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689582/
https://ncbi.nlm.nih.gov/pubmed/33239417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001558
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados